Back
HFA Premium Access

Temporality of events leading to the diagnosis of obstructive hypertrophic cardiomyopathy (oHCM): a machine learning approach using UK retrospective data

Session: Cardiomyopathies: present and future
Topic: Hypertrophic Cardiomyopathy
Speaker: Mr M. Hurst (London, GB)
Event: Heart Failure 2024

Congress Presentation

About the speaker

Mr Michael Hurst

Bristol Myers Squibb, London (United Kingdom of Great Britain & Northern Ireland)
1 presentation
0 follower

4 more presentations in this session

Mavacamten in a real-world hypertrophic cardiomyopathy population: how many may be eligible?

Speaker: Doctor M. Lima (Lisbon, PT)

Access
Abstract
Slides
Video
Thumbnail

DPD quantification correlates with ECV and disease severity in transthyretin cardiac amyloidosis

Speaker: Doctor R. Rettl (Vienna, AT)

Access
Abstract
Slides
Video
Thumbnail

ATTRibute-CM: ITT sensitivity analysis and sub-analysis comparing acoramidis and placebo in stage 4 CKD

Speaker: Professor S. Poulsen (Aarhus N, DK)

Access
Abstract
Slides
Video
Thumbnail

Delayed diagnosis of hypertrophic cardiomyopathy: results from electronic medical records analysis

Speaker: Doctor C. Mao (San Francisco, US)

Access
Abstract
Slides
Video
Thumbnail

Access the full session

Cardiomyopathies: present and future

Speakers: Mr M. Hurst, Doctor M. Lima, Doctor R. Rettl, Professor S. Poulsen, Doctor C. Mao
Access
Video
Thumbnail

About the event

Image

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources